Table 3 Estimated hazard ratios for treatment effect (active treatment versus placebo) and associated 95% confidence intervals, by frailty index
Stroke | Cardiovascular events | Total mortality | ||||
|---|---|---|---|---|---|---|
Frailty index | HR | 95% CI | HR | 95% CI | HR | 95% CI |
0.1 | 0.75 | 0.40–1.38 | 0.62 | 0.42–0.92 | 0.89 | 0.63–1.25 |
0.2 | 0.66 | 0.43–1.01 | 0.60 | 0.45–0.78 | 0.84 | 0.66–1.07 |
0.3 | 0.59 | 0.36–0.96 | 0.57 | 0.42–0.79 | 0.80 | 0.61–1.04 |
0.4 | 0.52 | 0.25–1.09 | 0.55 | 0.34–0.89 | 0.76 | 0.50–1.14 |
0.5 | 0.47 | 0.16–1.33 | 0.53 | 0.26–1.06 | 0.72 | 0.40–1.29 |
0.6 | 0.41 | 0.10–1.65 | 0.50 | 0.20–1.27 | 0.68 | 0.32–1.48 |